Masanori Okaniwa

1.9k total citations · 1 hit paper
26 papers, 1.4k citations indexed

About

Masanori Okaniwa is a scholar working on Molecular Biology, Organic Chemistry and Cell Biology. According to data from OpenAlex, Masanori Okaniwa has authored 26 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Organic Chemistry and 5 papers in Cell Biology. Recurrent topics in Masanori Okaniwa's work include Melanoma and MAPK Pathways (6 papers), Synthesis and biological activity (5 papers) and Microtubule and mitosis dynamics (5 papers). Masanori Okaniwa is often cited by papers focused on Melanoma and MAPK Pathways (6 papers), Synthesis and biological activity (5 papers) and Microtubule and mitosis dynamics (5 papers). Masanori Okaniwa collaborates with scholars based in Japan, United States and United Kingdom. Masanori Okaniwa's co-authors include Chris J. Novotny, Kevan M. Shokat, Tomoyasu Ishikawa, Reiko Yanada, Tomohiro Kawamoto, Teresa Klinowska, Claire McWhirter, Zhan Yao, Helen Won and Vanessa Rodrik-Outmezguine and has published in prestigious journals such as Nature, Nature Communications and Nature Materials.

In The Last Decade

Masanori Okaniwa

25 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity

2022 242 citations Eric L. Dane, Alexis Belessiotis‐Richards et al. Nature Materials profile →

Peers

Countries citing papers authored by Masanori Okaniwa

Since Specialization

Citations

This map shows the geographic impact of Masanori Okaniwa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masanori Okaniwa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masanori Okaniwa more than expected).

Fields of papers citing papers by Masanori Okaniwa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masanori Okaniwa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masanori Okaniwa. The network helps show where Masanori Okaniwa may publish in the future.

Co-authorship network of co-authors of Masanori Okaniwa

This figure shows the co-authorship network connecting the top 25 collaborators of Masanori Okaniwa. A scholar is included among the top collaborators of Masanori Okaniwa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masanori Okaniwa. Masanori Okaniwa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity breakdown → 2022 ·Nature Materials ·Eric L. Dane, Alexis Belessiotis‐Richards, Coralie M. Backlund, Jianing Wang, (unknown), Lauren E. Milling, Sachin Bhagchandani, Mariane B. Melo, Shengwei Wu, Na Li, Nathan D. Donahue, Kaiyuan Ni, Leyuan Ma, Masanori Okaniwa, Molly M. Stevens, Alfredo Alexander‐Katz, Darrell J. Irvine	242
2	Discovery of Novel Allosteric Inhibitors of Deoxyhypusine Synthase 2020 ·Journal of Medicinal Chemistry ·Yuta Tanaka, Osamu Kurasawa, (unknown), Michael G. Klein, Koji Ono, Bunnai Saito, Shigemitsu Matsumoto, Masanori Okaniwa, (unknown), Daisuke Morishita, Satoshi Kitazawa, Noriko Uchiyama, Kazumasa Ogawa, Hiromichi Kimura, Shinichi Imamura	19
3	Discovery and pharmacological characterization of a new class of prolyl-tRNA synthetase inhibitor for anti-fibrosis therapy 2017 ·PLoS ONE ·Akira Shibata, Masako Kuno, Ryutaro Adachi, Yosuke Sato, (unknown), Atsushi Matsuda, Yuumi Okuzono, (unknown), Yusuke Tominari, Terufumi Takagi, Masato Yabuki, Masanori Okaniwa	14
4	Design and synthesis of selective CDK8/19 dual inhibitors: Discovery of 4,5-dihydrothieno[3′,4′:3,4]benzo[1,2-d]isothiazole derivatives 2017 ·Bioorganic & Medicinal Chemistry ·Koji Ono, Hiroshi Banno, Masanori Okaniwa, Takaharu Hirayama, (unknown), (unknown), Saomi Murai, Maki Hasegawa, Yuka Hasegawa, Kazuko Yonemori, Akito Hata, Kazunobu Aoyama, Douglas R. Cary	27
5	A Kinase Inhibitor Targeted to mTORC1 Drives Regression in Glioblastoma 2017 ·Cancer Cell ·Qi-Wen Fan, Ozlem Aksoy, Robyn A. Wong, Shirin Ilkhanizadeh, Chris J. Novotny, W. Clay Gustafson, (unknown), Geraldine Cayanan, Erin F. Simonds, Daphne A. Haas‐Kogan, Joanna J. Phillips, Theodore Nicolaides, Masanori Okaniwa, Kevan M. Shokat, William A. Weiss	145
6	Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor 2016 ·Nature ·Vanessa Rodrik-Outmezguine, Masanori Okaniwa, Zhan Yao, Chris J. Novotny, Claire McWhirter, (unknown), Helen Won, Wai Wong, Mike Berger, Elisa de Stanchina, Derek Barratt, Sabina Cosulich, Teresa Klinowska, Neal Rosen, Kevan M. Shokat	341
7	Design and synthesis of fused bicyclic inhibitors targeting the L5 loop site of centromere-associated protein E 2016 ·Bioorganic & Medicinal Chemistry Letters ·Takaharu Hirayama, Masanori Okaniwa, Hiroshi Banno, Hiroyuki Kakei, Akihiro Ohashi, Momoko Ohori, Tadahiro Nambu, Kenichi Iwai, Tomohiro Kawamoto, (unknown), Maki Miyamoto, Tomoyasu Ishikawa	2
8	Abstract 2147: Overcoming mTOR resistance mutations with a new generation mTOR inhibitor 2016 ·Cancer Research ·Vanessa Rodrik-Outmezguine, Masanori Okaniwa, Zhan Yao, Chris J. Novotny, Claire McWhirter, (unknown), Helen Won, Wai Wong, Mike Berger, Elisa de Stanchina, Derek Barratt, Sabina Cosulich, Teresa Klinowska, Neal Rosen, Kevan M. Shokat	0
9	A Novel Time-Dependent CENP-E Inhibitor with Potent Antitumor Activity 2015 ·PLoS ONE ·Akihiro Ohashi, Momoko Ohori, Kenichi Iwai, Tadahiro Nambu, Maki Miyamoto, Tomohiro Kawamoto, Masanori Okaniwa	26
10	Aneuploidy generates proteotoxic stress and DNA damage concurrently with p53-mediated post-mitotic apoptosis in SAC-impaired cells 2015 ·Nature Communications ·Akihiro Ohashi, Momoko Ohori, Kenichi Iwai, Yusuke Nakayama, Tadahiro Nambu, Daisuke Morishita, Tomohiro Kawamoto, Maki Miyamoto, Takaharu Hirayama, Masanori Okaniwa, Hiroshi Banno, Tomoyasu Ishikawa, Hitoshi Kandori, Kentaro Iwata	132
11	Antitumor Activity of the Selective Pan-RAF Inhibitor TAK-632 in BRAF Inhibitor-Resistant Melanoma 2013 ·Cancer Research ·Akito Nakamura, Takeo Arita, (unknown), Jill Donelan, (unknown), Elizabeth Carideo, Katherine Galvin, Masanori Okaniwa, Tomoyasu Ishikawa, Sei Yoshida	92
12	Synthetic studies of centromere-associated protein-E (CENP-E) inhibitors: 1.Exploration of fused bicyclic core scaffolds using electrostatic potential map 2013 ·Bioorganic & Medicinal Chemistry ·Takaharu Hirayama, Masanori Okaniwa, Takashi Imada, Akihiro Ohashi, Momoko Ohori, Kenichi Iwai, Kouji Mori, Tomohiro Kawamoto, (unknown), Toshimasa Tanaka, Tomoyasu Ishikawa	20
13	Discovery of a Selective Kinase Inhibitor (TAK-632) Targeting Pan-RAF Inhibition: Design, Synthesis, and Biological Evaluation of C-7-Substituted 1,3-Benzothiazole Derivatives 2013 ·Journal of Medicinal Chemistry ·Masanori Okaniwa, Masaaki Hirose, Takeo Arita, Masato Yabuki, Akito Nakamura, Terufumi Takagi, Tomohiro Kawamoto, Noriko Uchiyama, (unknown), Shunichirou Tsutsumi, (unknown), Yoshitaka Inui, Bi‐Ching Sang, Jason K. Yano, Kathleen Aertgeerts, Sei Yoshida, Tomoyasu Ishikawa	90
14	Use of combination treatment with the investigational RAF kinase inhibitor MLN2480 and the investigational MEK kinase inhibitor TAK-733 on the growth of BRAF-mutant and RAS-mutant preclinical models of melanoma and CRC. 2013 ·Journal of Clinical Oncology ·(unknown), Julie Zhang, (unknown), Jerome T. Mettetal, Kazuhide Nakamura, Takeo Arita, Akito Nakamura, Masanori Okaniwa, Tomoyasu Ishikawa, Sei Yoshida, (unknown), Patrick W. Vincent, (unknown), Khristofer Garcia, (unknown), (unknown), (unknown), Saurabh Menon, Mike Kuranda, Katherine Galvin	1
15	Design and synthesis of novel DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors: 2. Synthesis and characterization of a novel imide-type prodrug for improving oral absorption 2012 ·Bioorganic & Medicinal Chemistry ·Masanori Okaniwa, Takashi Imada, Tomohiro Ohashi, T. Miyazaki, Takeo Arita, Masato Yabuki, (unknown), Shunichirou Tsutsumi, (unknown), Terufumi Takagi, Tomohiro Kawamoto, Yoshitaka Inui, Sei Yoshida, Tomoyasu Ishikawa	8
16	The DSL domain in mutant JAG1 ligand is essential for the severity of the liver defect in Alagille syndrome 2001 ·Clinical Genetics ·(unknown), Masanori Okaniwa, I Nagata, (unknown), Mikiko Ito, (unknown), Yukihiro Inomata, (unknown), (unknown), Norihiro Kobayashi, Takao Kohsaka	18
17	Aluminum-Controlled Reactivity and Diastereoselectivity toward Radical Reactions of Optically Active Aldimines with Metallic Samarium 2001 ·The Journal of Organic Chemistry ·Reiko Yanada, Masanori Okaniwa, (unknown), Toshiro Ibuka, Yoshiji Takemoto	23
18	Diastereoselective allylation and alkylation of optically active imines with metallic samarium and a catalytic amount of iodine 1999 ·Tetrahedron ·Reiko Yanada, Nobuyuki Negoro, Masanori Okaniwa, Toshiro Ibuka	39
19	Samarium-promoted Diastereoselective Reductive Coupling of Optically Active Imines 1999 ·Synlett ·Reiko Yanada, Nobuyuki Negoro, Masanori Okaniwa, Yoshihisa Miwa, Tooru Taga, Kazuo Yanada, Tetsuro Fujita	27
20	Diastereoselective Allylation of Optically Active Imines with Metallic Samarium 1998 ·Synlett ·Nobuyuki Negoro, Reiko Yanada, Masanori Okaniwa, Kazuo Yanada, Tetsuro Fujita	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact